Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease.
Publication/Presentation Date
8-1-2008
Abstract
BACKGROUND: This study was conducted to assess the care of pediatric patients hospitalized for sickle cell disease-related vasoocclusive episodes (VOE). The aim of this research was to illustrate the course of pain scores and methods of therapeutic intervention during hospitalization.
PROCEDURE: Retrospective medical chart reviews were conducted to collect pain assessment and management data about children hospitalized during a 2-year period at an urban children's hospital. T tests and Chi-square analyses were used to identify differences in demographic variables, pain scores and opiate utilization.
RESULTS: There were 59 children with 134 hospitalizations for VOE in a 2-year period. 50.8% of the patients were male; the mean age was 11.5 +/- 4.9 years. The average length of hospitalization was 4.6 +/- 2.7 days (range 1-19 days). Older patients stayed in the hospital significantly longer than younger patients (P = 0.002). Pain scores remained in the moderate to severe range (> or =5 out of 10) for many days in the majority of patients. Results failed to reveal significant differences in pain scores and opiate utilization between patients who had short versus extended hospitalizations, and for those patients with frequent versus infrequent hospitalizations for pain.
CONCLUSIONS: Despite opiate dosing within recommended guidelines, mean pain scores remain in the moderate to severe range for several days following hospitalization for VOE. Future research should explore the factors which influence pain scores, as well as improved pain assessment and management techniques.
Volume
51
Issue
2
First Page
265
Last Page
268
ISSN
1545-5017
Published In/Presented At
Zempsky, W. T., Loiselle, K. A., McKay, K., Blake, G. L., Hagstrom, J. N., Schechter, N. L., & Kain, Z. N. (2008). Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease. Pediatric blood & cancer, 51(2), 265–268. https://doi.org/10.1002/pbc.21572
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
18386784
Department(s)
Department of Pediatrics
Document Type
Article